Compositions And Methods For Treating Gulf War Illness
OwnerBruce Citroninventor
Life of this patent
Estimating the term…
Abstract
The disclosure relates to compositions and methods of treating Gulf War illness or syndrome in a subject. The method comprises administering to a subject in need of treatment an effective amount of a nuclear receptor peroxisome proliferator-activated receptor gamma agonist and a nuclear factor erythroid 2-related factor 2 agonist.
Claims25
A method of treating of Gulf War illness or syndrome in a subject, the method comprising:
- administering to the subject in need thereof a therapeutically effective amount of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a nuclear factor erythroid 2-related factor 2 (Nrf2) agonist.
(canceled)
(canceled)
A method of ameliorating one or more symptoms of ameliorating one or more symptoms of Gulf War illness or syndrome in a subject, the method comprising:
- administering to the subject in need thereof a therapeutically effective amount of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a nuclear factor erythroid 2-related factor 2 (Nrf2) agonist.
A method of inhibiting neurodegeneration or effecting neuroprotection in a subject in need thereof, the method comprising:
- administering to the subject in need thereof a therapeutically effective amount of a nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a nuclear factor erythroid 2-related factor 2 (Nrf2) agonist.
(canceled)
(canceled)
-31. (canceled)
Dependencies are inferred from the claim text.